Skip to main content

Agilent Technologies, Inc. (A) Stock Analysis

SellModerate Confidence

Healthcare · Diagnostics & Research

Sell if holding. Momentum 1.4/10 is below the 5.0 floor at $114.33 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Weak growth.

Agilent Technologies provides instruments, software, services, and consumables for laboratory workflows across life sciences, diagnostics, and applied markets through three segments globally. Customers include pharma/biopharma companies, clinical labs, and industrial... Read more

$114.33+26.4% A.UpsideScore 5.1/10#15 of 25 Diagnostics & Research
Stop $107.30Target $144.62(analyst − 10%)A.R:R 4.3:1
Analyst target$160.69+40.5%16 analysts
$144.62our TP
$114.33price
$160.69mean
$185

Sell if holding. Momentum 1.4/10 is below the 5.0 floor at $114.33 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Weak growth. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.1/10, moderate confidence.

Passes 5/8 gates (favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 27d clear, semi cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA). Suitability: aggressive.

Thesis

Rewards
High-quality business
Analyst upside: 26%
Risks
Weak growth
Negative momentum
Below 200-day MA

Key Metrics

P/E (TTM)24.6
P/E (Fwd)16.9
Mkt Cap$31.5B
EV/EBITDA16.9
Profit Mgn18.3%
ROE19.9%
Rev Growth7.0%
Beta1.30
Dividend0.92%
Rating analysts28

Quality Signals

Piotroski F8/9

Options Flow

P/C3.97bearish
IV43%normal
Max Pain$200+74.9% vs spot

Material Events(8-K, last 90d)

  • 2026-04-06Item 5.02MEDIUM
    Bret DiMarco, SVP and Chief Legal Officer, entered transition agreement March 31, 2026. Will resign upon start of new CLO or Sept 30, 2026; continues as Special Advisor through Dec 1, 2026. No permanent successor named.
    SEC filing →
  • 2026-03-06Item 5.02LOW
    Rodney Gonsalves, VP Corporate Controller and Principal Accounting Officer, notified Company of intent to retire in January 2027. No disagreement cited; advance notice allows succession search.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Macd
0.0
Volume
0.0
Obv
1.0
Ma Position
1.5
Rsi
4.5
Volume distribution (falling OBV)Below 200-MA, MA slope flat

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
1.3
Revenue Growth
4.2
GatesMomentum 1.4<4.5Death cross (50MA < 200MA)Executive change: officer departure/appointmentA.R:R 4.2 ≥ 1.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 27d clearSEMI CYCLE PEAK CLEARSuitability: Aggressive
RSI
49 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $110.31Resistance $124.89

Price Targets

$107
$145
A.Upside+26.5%
A.R:R4.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Momentum score 1.4/10 — below 4.5 minimum
! Death cross — 50-day MA below 200-day MA

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-05-27 (27d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is A stock a buy right now?

Sell if holding. Momentum 1.4/10 is below the 5.0 floor at $114.33 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Negative momentum; Weak growth. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $107.30. Score 5.1/10, moderate confidence.

What is the A stock price target?

Take-profit target: $144.62 (+26.4% upside). Prior stop was $107.30. Stop-loss: $107.30.

What are the risks of investing in A?

Weak growth; Negative momentum; Below 200-day MA.

Is A overvalued or undervalued?

Agilent Technologies, Inc. trades at a P/E of 24.6 (forward 16.9). TrendMatrix value score: 6.4/10. Verdict: Sell.

What do analysts say about A?

28 analysts cover A with a consensus score of 4.0/5. Average price target: $161.

What does Agilent Technologies, Inc. do?Agilent Technologies provides instruments, software, services, and consumables for laboratory workflows across life...

Agilent Technologies provides instruments, software, services, and consumables for laboratory workflows across life sciences, diagnostics, and applied markets through three segments globally. Customers include pharma/biopharma companies, clinical labs, and industrial manufacturers; ~18,100 employees as of October 2025.

Related stocks: IQV (IQVIA Holdings, Inc.) · BLLN (BillionToOne, Inc.) · SHC (Sotera Health Company) · QGEN (Qiagen N.V.) · GH (Guardant Health, Inc.)